10.18710/4YN9SZKilvaer, Thomas KThomas KKilvaer0000-0003-1669-0117UiT The Arctic University of NorwayUiT_TILs - Replication Data for "A Pragmatic Machine Learning Approach to Quantify Tumor Infiltrating Lymphocytes in Whole Slide Images"DataverseNO2021Medicine, Health and Life Sciencesmachine learningMLdeep learningDLnon-small cell lung cancerCarcinoma, Non-Small-Cell Lungimmune celltissue infiltrating lymphycytesTILKilvaer, Thomas KThomas KKilvaerUiT The Arctic University of NorwayUiT The Arctic University of NorwayUiT The Arctic University of NorwayUiT The Arctic University of Norway2020-01-012021-01-192023-09-282006-01-01/2017-01-01clinical data2039820000000002000000000891084800193444864052428800005242880000524288000052428800005242880000524288000052428800005242880000524288000052428800003445852160text/plainapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/x-tarapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-streamapplication/octet-stream2.1CC0 1.0This dataset can be used to replicate the findings in "A Pragmatic Machine Learning Approach to Quantify Tumor Infiltrating Lymphocytes in Whole Slide Images". The motivation for this paper is that increased levels of tumor infiltrating lymphocytes (TILs) indicate favorable outcomes in many types of cancer. Our aim is to leverage computational pathology to automatically quantify TILs in standard diagnostic whole-tissue hematoxylin and eosin stained section slides (H&E slides). Our approach is to transfer an open source machine learning method for segmentation and classification of nuclei in H&E slides trained on public data to TIL quantification without manual labeling of our data. Our results show that improved data augmentation improves immune cell detection in H&E WSIs. Moreover, the resulting TIL quantification correlates to patient prognosis and compares favorably to the current state-of-the-art method for immune cell detection in non-small lung cancer (current standard CD8 cells in DAB stained TMAs HR 0.34 95% CI 0.17-0.68 vs TILs in HE WSIs: HoVer-Net PanNuke Model HR 0.30 95% CI 0.15-0.60). Moreover, we implemented a cloud based system to train, deploy, and visually inspect machine learning based annotation for H&E slides. Our pragmatic approach bridges the gap between machine learning research, translational clinical research and clinical implementation. However, validation in prospective studies is needed to assert that the method works in a clinical setting. The dataset is comprised of three parts: 1) Twenty image patches with and without overlays used by pathologists to manually evaluate the output of the deep learning models, 2) The models trained and subsequently used for inference in the paper, 3) the patient dataset with corresponding image patches used to clinically validate the output of the deep learning models. The tissue samples were collected from patients diagnosed between 1993 and 2003. Supplementing information was collected retrospectively in the time period 2006-2017. The images were produced in 2017.TromsoNorth Norwegian Health AuthorityHNF1521-20